News Focus
News Focus
Followers 2
Posts 1360
Boards Moderated 0
Alias Born 01/05/2018

Re: None

Wednesday, 07/20/2022 9:17:53 AM

Wednesday, July 20, 2022 9:17:53 AM

Post# of 21574
"Synaptogenix Advances Dosing of First Patient in Dose Optimization Clinical Trial in Preparation for NIH-Sponsored, Phase 2 Alzheimer's Disease Trial Data"

https://www.prnewswire.com/news-releases/synaptogenix-advances-dosing-of-first-patient-in-dose-optimization-clinical-trial-in-preparation-for-nih-sponsored-phase-2-alzheimers-disease-trial-data-301589937.html
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent TAOX News